You are here: Industry Insights > Spark

News List

Spark™ Aligners Receive FDA Clearance For Orthodontic Treatment Of Kids, Giving Parents A New Option With Significant Treatment Advantages Over The Leading Competitor prnasia
June 17, 2021
Ormco Corporation, a global leader of orthodontic solutions, announced it has received U.S. Food and Drug Administration (FDA) clearance for the use of its Spark™ Clear Aligner System for orthodontic treatment in patients with both primary and ...
Spark Therapeutics Appoints CTO contractpharma
March 01, 2021
Cynthia Pussinen will oversee manufacturing and technical operations, including pipeline process development, preclinical and clinical manufacturing.
Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy worldpharmanews
December 20, 2019
Roche and Spark Therapeutics, Inc. announced the completion of the acquisition following the receipt of regulatory approval from all government authorities required by the merger agreement.
Roche gets UK and US clearances for Spark Therapeutics acquisition pharmaceutical-technology
December 18, 2019
Swiss healthcare company Roche has received clearances in the UK and US for its proposed acquisition of US-based gene therapy company Spark Therapeutics for $4.8bn.
Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. worldpharmanews
September 04, 2019
Roche and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares...
Roche extends $4.3B Spark tender offer yet again. What are watchdogs so worried about? fiercepharma
August 01, 2019
You might have lost count of how many times Roche has extended the tender offer period for shares of Spark Therapeutics. As of Wednesday, it's five. And once again, regulatory delays are part of the problem.
Regulators demand more details on Roche’s $4.8bn Spark acquisition pharmaceutical-technology
June 13, 2019
The US Federal Trade Commission (FTC) has requested that both Roche and Spark Therapeutics submit additional information and documentary material regarding their proposed merger agreement.
Roche forced to extend Spark tender offer as investors sue over $4.3B merger fiercepharma
April 04, 2019
Roche’s $114.50-per-share offer for Spark Therapeutics represents a whopping 122% premium to the gene specialist’s
Axovant pivots with new gene therapy, Spark co-founder as CTO fiercebiotech
June 11, 2018
After a disastrous year in which its Alzheimer’s attempts blew up and the once biotech star David Hung jumped ship, Axovant is continuing its change-up with a new focus and a new executive.
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. biospace
December 20, 2017
FDA broke new ground today with a first-of-its-kind therapy for eye disease. The regulatory agency approved Spark Therapeutics' Luxturna (voretigene neparvovec), a gene therapy for a rare, genetic form of blindness.